With Future Biology filing applications at such speed, the leaders at the drug administration decided they had to get a handle on things. Otherwise, the entire agency would end up working for Future Biology. So they summoned Lin Dongzhe for a meeting.
In their view, everything followed certain rules. Even if Wang Yue had an edge in materials and in designing aircraft carriers' electronic systems, those things were ultimately related to mechanical engineering. At most, they proved that Wang Yue was a mechanical genius.
But pharmaceuticals and biology had nothing to do with mechanical manufacturing. A person's energy was limited, too. Wang Yue had shown such talent in mechanical engineering, so it was simply impossible for him to switch fields and develop so many drugs, all of which could pass clinical trials.
The drug administration worried that Lin Dongzhe was using his connection to Wang Yue to push drugs that weren't fully developed onto the market, so they sent people to investigate.
Though Lin Dongzhe had no idea where Wang Yue had gotten the prescriptions, he had analyzed the drugs' ingredients and had experts from various fields examine them. Their conclusion was that the products really would have medicinal effects.
So when the drug administration's special investigators came to question him, Lin Dongzhe simply took out a stack of prescriptions.
Lin Dongzhe, of course, wasn't about to sell Wang Yue out. He calmly spun them a story. "My brother Wang paid a fortune to have his overseas partners purchase these technologies abroad.
"Many of them are still at the laboratory stage, and a lot haven't even gone on sale yet. So we need to verify them. That's why Future Biology was founded in the first place.
"Brother Wang never intended to make money from this. There was just so much